Len Yaffe

Stoc*Doc Partners

Image: Len Yaffe

Len Yaffe has spent 30 years analyzing the healthcare sector, and he currently runs Stoc*Doc Partners, a healthcare hedge fund in San Francisco. He holds an MD from the Feinberg School of Medicine, Northwestern University.

Recent Quotes

"There are few stocks with similar upside potential to DRRX."

— Len Yaffe, Seeking Alpha (3/23/18)
more >

"I continue to highlight DRRX, whose DUR-928 looks very promising, albeit in early stage clinical trials."

— Len Yaffe, Stoc*Doc Partners (12/20/16)
more >

"The recent weakness in pharmaceutical stocks affords an excellent buying opportunity in select names with promising pipelines, including DRRX.

The Life Sciences Report Article by Dr. Len Yaffe (11/2/16)
more >

"I am impressed with the very early data on DRRX's endogenous small molecule, DUR-928."

— Len Yaffe, Stoc*Doc Partners (10/20/16)
more >

Due to permission requirements, not all quotes are shown.